脑组织氧饱和度与循环性休克患者谵妄发生的关系:一项前瞻性观察性队列研究
ASSESS-SHOCK为前瞻性、观察性、多中心研究(2019年4月至2023年5月),纳入256例成人循环性休克患者,于ICU入科24小时内入组,用INVOS™ NIRS连续监测cStO2 48小时。主要终点0-48小时时间加权平均cStO2与第1-7天谵妄发生无关:谵妄组61.6%(IQR 57.3-67.7) vs 无谵妄组63.1%(IQR 57.7-68.1),p=0.716。次要终点中,较低时间加权平均cStO2与90天死亡率升高相关:非存活者60.0%(IQR 52.8-64.7) vs 存活者63.9%(IQR 58.1-68.9),p<0.001。结论提示NIRS监测或可作为识别不良结局(包括死亡)高危患者的辅助方法。
要点
- 在256例循环性休克患者中,0-48小时时间加权平均cStO2与第1-7天谵妄发生无关联(61.6% vs 63.1%,p=0.716)。
- 较低的时间加权平均cStO2与90天死亡率升高相关:非存活者60.0%(IQR 52.8-64.7) vs 存活者63.9%(IQR 58.1-68.9),p<0.001。
- 研究使用INVOS™ NIRS设备连续监测cStO2 48小时,并计算时间加权均值及预设阈值60%、50%、40%以下的面积。
- NIRS监测可能作为辅助方法识别循环性休克中死亡高风险患者,但原文未给出具体决策阈值。
- 谵妄在循环性休克患者中发生率为34%(87/256),原文未提及谵妄评估工具。
适用人群与场景
- 成人循环性休克患者,于ICU入科24小时内入组(ASSESS-SHOCK研究)。
诊断标准与关键阈值
- 原文未提及cStO2的启动或停止治疗阈值;研究预设阈值60%、50%、40%仅用于计算低于阈值的面积。
处置流程与药物剂量
- 原文未提及基于cStO2的具体处置流程或药物剂量。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:前瞻性、观察性、多中心队列研究(ASSESS-SHOCK,NCT03814564),2019年4月至2023年5月。
- 样本量与中心数:纳入256例成人循环性休克患者;原文未提及中心数。
- 干预与对照:无干预对比;连续监测cStO2 48小时(INVOS™ NIRS),计算时间加权均值及低于60%、50%、40%阈值的面积。
- 主要终点:0-48小时时间加权平均cStO2与第1-7天谵妄发生无关;谵妄组61.6%(IQR 57.3-67.7) vs 无谵妄组63.1%(IQR 57.7-68.1),p=0.716;87例(34%)发生谵妄。
- 关键次要终点:较低时间加权平均cStO2与90天死亡率升高相关;非存活者60.0%(IQR 52.8-64.7) vs 存活者63.9%(IQR 58.1-68.9),p<0.001;原文未提及ICU死亡率的具体结果数值。
- 不良事件:原文未提及。
证据类型、等级与局限
- 证据类型:前瞻性观察性多中心队列研究。
- 局限:观察性设计无法确立因果关系;原文未提及单中心、回顾性、开放标签或样本量局限。
对床旁实践的改变
- 原文结论提示NIRS监测cStO2或可作为辅助方法识别循环性休克中90天死亡高风险患者,但cStO2与谵妄发生无关,不应据此预测或预防谵妄。
- 原文未给出cStO2的具体决策阈值,不能将研究中的预设阈值(60%、50%、40%)或观察到的均值直接作为临床干预阈值。
- 适用人群为ICU入科24小时内的成人循环性休克患者;原文未提及不适用人群。
指南或共识出处
- 原文未提及指南或共识出处;试验注册号ClinicalTrials.gov NCT03814564。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Delirium is a frequent neuropsychiatric complication in critical illness associated with increased risk of long-term cognitive impairment and mortality. We hypothesized that lower cerebral tissue oxygen saturation (cStO2) levels measured with near infrared spectroscopy (NIRS) associate with worse outcome, including mortality, and the risk for developing delirium in circulatory shock. We conducted the prospective, observational, multi-center study (ASSESS-SHOCK, ClinicalTrials.gov: NCT03814564), from April 2019 to May 2023. We enrolled adult circulatory shock patients within 24 hours of intensive care unit (ICU) admission. We registered cStO2 continuously for 48 hours using INVOS™ NIRS devices. We calculated the time-weighted mean cStO2 values and areas under the predefined thresholds of 60%, 50%, and 40% respectively. The primary objective was the association of time-weighted mean cStO2 during 0-48 hours with development of delirium during days 1-7. Secondary endpoints were ICU- and 90-day mortality. We included 256 patients, of whom 87 (34%) developed delirium. The 0-48 h mean cStO2 values did not differ between patients with and without delirium: 61.6% (interquartile range [IQR] 57.3 to 67.7) vs 63.1% (IQR 57.7 to 68.1, p=0.716), respectively. Lower time-weighted mean cStO2 during 48 hours was, however, associated with higher 90-day mortality: in non-survivors cStO2 was 60.0% (IQR 52.8 to 64.7) compared to 63.9% (IQR 58.1 to 68.9) in survivors (p<0.001). Conclusions: In circulatory shock, lower mean cStO2 values were not associated with delirium but they were associated with 90-d mortality. NIRS monitoring could serve as an adjunct method for identifying patients at risk for developing adverse outcomes, including mortality. Trial registration: ClinicalTrials.gov Identifier: NCT03814564, registered 15 January 2019. The ASSESS-SHOCK study: Assessment of peripheral perfusion, tissue oxygen saturation, endothelial function, and coagulation disorder in circulatory shock.
参考来源
- Heliste M, Varis E, Hästbacka J, et al. Association of cerebral tissue oxygen saturation with the development of delirium in circulatory shock - a prospective observational cohort study. Shock. 2026. PMID: 42627201. doi:10.1097/SHK.0000000000002925
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。